141 related articles for article (PubMed ID: 8319201)
1. Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.
Felix CA; Winick NJ; Negrini M; Bowman WP; Croce CM; Lange BJ
Cancer Res; 1993 Jul; 53(13):2954-6. PubMed ID: 8319201
[TBL] [Abstract][Full Text] [Related]
2. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.
Thirman MJ; Gill HJ; Burnett RC; Mbangkollo D; McCabe NR; Kobayashi H; Ziemin-van der Poel S; Kaneko Y; Morgan R; Sandberg AA
N Engl J Med; 1993 Sep; 329(13):909-14. PubMed ID: 8361504
[TBL] [Abstract][Full Text] [Related]
3. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
[TBL] [Abstract][Full Text] [Related]
4. 11q23 aberration is an additional chromosomal change in de novo acute leukemia after treatment with etoposide and mitoxantrone.
Ohshima A; Miura I; Chubachi A; Hashimoto K; Nimura T; Utsumi S; Takahashi N; Hayashi Y; Seto M; Ueda R; Miura AB
Am J Hematol; 1996 Dec; 53(4):264-6. PubMed ID: 8948668
[TBL] [Abstract][Full Text] [Related]
5. Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations.
Caligiuri MA; Schichman SA; Strout MP; Mrózek K; Baer MR; Frankel SR; Barcos M; Herzig GP; Croce CM; Bloomfield CD
Cancer Res; 1994 Jan; 54(2):370-3. PubMed ID: 8275471
[TBL] [Abstract][Full Text] [Related]
6. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].
Dassonneville L; Bailly C
Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
Smith MA; Rubinstein L; Ungerleider RS
Med Pediatr Oncol; 1994; 23(2):86-98. PubMed ID: 8202047
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
Pui CH; Ribeiro RC; Hancock ML; Rivera GK; Evans WE; Raimondi SC; Head DR; Behm FG; Mahmoud MH; Sandlund JT
N Engl J Med; 1991 Dec; 325(24):1682-7. PubMed ID: 1944468
[TBL] [Abstract][Full Text] [Related]
9. Distinct MLL gene rearrangements associated with successive acute monocytic and lymphoblastic leukemias in the same patient.
Jonveaux P; Hillion J; Bernard O; Le Coniat M; Derré J; Flexor M; Larsen CJ; Berger R
Leukemia; 1994 Dec; 8(12):2224-7. PubMed ID: 7808011
[TBL] [Abstract][Full Text] [Related]
10. [Secondary leukemia after etoposide treatment involved MLL gene rearrangement].
Iida H; Taji H; Iida M; Suzuki R; Sugihara T; Minami S; Kodera Y; Yamamoto K; Seto M; Ueda R
Rinsho Ketsueki; 1994 Jun; 35(6):569-75. PubMed ID: 8078192
[TBL] [Abstract][Full Text] [Related]
11. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
Sinclair P; Harrison CJ; Jarosová M; Foroni L
Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
[TBL] [Abstract][Full Text] [Related]
12. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
Felix CA; Hosler MR; Winick NJ; Masterson M; Wilson AE; Lange BJ
Blood; 1995 Jun; 85(11):3250-6. PubMed ID: 7756657
[TBL] [Abstract][Full Text] [Related]
13. Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia.
Stasik C; Ganguly S; Cunningham MT; Hagemeister S; Persons DL
Cancer Genet Cytogenet; 2006 Jul; 168(2):146-9. PubMed ID: 16843104
[TBL] [Abstract][Full Text] [Related]
14. A novel translocation, t(9;11)(q33;q23) involving the HRX gene in an acute monocytic leukemia.
Le Coniat M; Romana SP; Bernard O; Flexor MA; Hillion J; Cherif D; Berger R
C R Acad Sci III; 1993 Jul; 316(7):692-7. PubMed ID: 8019892
[TBL] [Abstract][Full Text] [Related]
15. Leukemia in infants.
Felix CA; Lange BJ
Oncologist; 1999; 4(3):225-40. PubMed ID: 10394590
[TBL] [Abstract][Full Text] [Related]
16. Inversion of chromosome 11 inv(11)(p15q22), as a recurring chromosomal aberration associated with de novo and secondary myeloid malignancies: identification of a P1 clone spanning the 11q22 breakpoint.
Kobayashi H; Arai Y; Hosoda F; Maseki N; Hayashi Y; Eguchi H; Ohki M; Kaneko Y
Genes Chromosomes Cancer; 1997 Jul; 19(3):150-5. PubMed ID: 9218995
[TBL] [Abstract][Full Text] [Related]
17. Secondary leukemias induced by topoisomerase-targeted drugs.
Felix CA
Biochim Biophys Acta; 1998 Oct; 1400(1-3):233-55. PubMed ID: 9748598
[TBL] [Abstract][Full Text] [Related]
18. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia.
Raza-Egilmez SZ; Jani-Sait SN; Grossi M; Higgins MJ; Shows TB; Aplan PD
Cancer Res; 1998 Oct; 58(19):4269-73. PubMed ID: 9766650
[TBL] [Abstract][Full Text] [Related]
19. Chromatin structural elements and chromosomal translocations in leukemia.
Zhang Y; Rowley JD
DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
[TBL] [Abstract][Full Text] [Related]
20. Hunting 11q23 deletions with fluorescence in situ hybridization (FISH).
Cherif D; Bernard O; Paulien S; James MR; Le Paslier D; Berger R
Leukemia; 1994 Apr; 8(4):578-86. PubMed ID: 8152254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
